Latest News and Press Releases

New demonstration of the predictive power of an in silico clinical trial in oncology Quantitative Systems Pharmacology (QSP) model of lung cancer and 5,900 digital patients architected to complete...

Novadiscovery announces Nature Communications paper on modeling the disruption to respiratory clinical trials due to mitigation measures against COVID-19 Model uses virtual populations and in silico...

Novadiscovery expands Janssen collaboration by implementing its JINKO® clinical trial simulation platform for the development of lung cancer models Janssen intends to use computational disease models...

Novadiscovery Continues Global Expansion with the Launch of its US Headquarters in Boston, MA The new office will support continued expansion into the US market, NOVA’s largest customer base, and...

Novadiscovery appoints Grégoire Boutonnet as Chief Operating Officer Appointment of Grégoire supports NOVA’s continued international expansion Lyon, France – 22 July 2021: Novadiscovery (NOVA), a...

Novadiscovery announces new clinical simulation collaboration with Takeda Lyon, France – 26 March, 2021 Novadiscovery (“NOVA”), a leading health tech company offering JINKO, a best-in-class...

Novadiscovery announces new clinical simulation collaboration with Takeda Lyon, France – 26 March, 2021 Novadiscovery (“NOVA”), a leading health tech company offering JINKO, a best-in-class...

Novadiscovery raises Series A2 financing from Sanofi to advance JINKO, its best-in-class clinical trial simulation platform NOVA to develop COVID-19 disease model to support Sanofi’s vaccine and...

Novadiscovery raises Series A2 financing from Sanofi to advance JINKO, its best-in-class clinical trial simulation platform NOVA to develop COVID-19 disease model to support Sanofi’s vaccine and...

Consortium including ElsaLys Biotech and Novadiscovery awarded €3.35 million by Bpifrance to advance inolimomab in graft-versus-host disease NOVA awarded €2.4 million to leverage Jinkō®, its...